在剖腹产中对普罗波福的目标控制输液到分娩时间的模拟:一项基准研究
Ilja Osthoff1, Monica Soare1, Giulio Barana1
1Institute for Anesthesia, Spital Thurgau, 8500 Frauenfeld, Switzerland.
Journal of clinical medicine
|October 29, 2025
概括
用于剖腹产 (CD) 的普罗波福尔向控制输液 (TCI) 在输液暂停期间显示药物管理最小. 在高达50%的模拟病例中,分娩发生在休息期间,特别是在紧急情况下.
科学领域:
- 麻醉学 麻醉学
- 药理动力学 药理动力学
- 产科 产科 产科 产科 产科
背景情况:
- 一般麻醉有时是必要的剖腹产 (CD).
- 普罗波的目标控制输注 (TCI) 使用药物动力学模型来准确的药物输送.
- 在TCI期间发生输液暂停,即从诱导剂量过渡到维持剂量.
研究的目的:
- 模拟从诱导到在CD中交付的propofol的管理.
- 估计在TCI输液暂停期间发生的分娩比例.
- 分析影响分娩时间的因素,相对于普罗波的输液暂停.
主要方法:
- 一项模拟研究使用了50名接受CD的女性的手术数据.
- 人口统计数据被输入到TCI中,使用施奈德的药理动力学模型.
- 模拟效应部位目标:诱导时6和8微克/毫升,然后维持时2.5微克/毫升.
主要成果:
- 在诱导分娩期间,估计的普罗波福尔平均剂量为19 ± 22毫克 (在6毫克克朗/毫升) 和13 ± 17毫克 (在8毫克克朗/毫升).
- 在模拟病例的40% (6毫克克/毫升) 和50% (8毫克克/毫升) 中,输液暂停期间发生了分娩.
- 紧急CD状态预测停顿期间的分娩;年龄和BMI没有.
结论:
- 标准化的TCI具有较低的维护目标,导致在诱导和分娩之间适度使用普罗波.
- 需要进行临床研究来证实这些模拟发现.
- 在临床实践中,对麻醉深度的监测应指导 пропофол的剂量.
相关概念视频
Parenteral Anesthetics: Overview
570
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
570
One-Compartment Open Model for IV Bolus Administration: General Considerations
674
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
674


